142 related articles for article (PubMed ID: 24132114)
1. Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation.
Commereuc M; Karras A; Amrein C; Boussaud V; Sberro-Soussan R; Guillemain R; Bacchi VF; Thervet E
Transplantation; 2013 Oct; 96(8):e58-9. PubMed ID: 24132114
[No Abstract] [Full Text] [Related]
2. Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.
Wilson CH; Brown AL; White SA; Goodship TH; Sheerin NS; Manas DM
Transplantation; 2011 Oct; 92(8):e42-3. PubMed ID: 21989273
[No Abstract] [Full Text] [Related]
3. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab.
Morales E; Rabasco C; Gutierrez E; Praga M
Transpl Int; 2015 Jul; 28(7):878-80. PubMed ID: 25712140
[No Abstract] [Full Text] [Related]
4. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
Peffault de Latour R; Xhaard A; Fremeaux-Bacchi V; Coppo P; Fischer AM; Helley D; Socié G
Br J Haematol; 2013 Apr; 161(2):279-80. PubMed ID: 23294015
[No Abstract] [Full Text] [Related]
5. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
[TBL] [Abstract][Full Text] [Related]
6. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
[TBL] [Abstract][Full Text] [Related]
7. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab.
Iqbal Z; Wood K; Carter V; Goodship TH; Brown AL; Sheerin NS
Transplant Proc; 2015 Sep; 47(7):2258-61. PubMed ID: 26361694
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab therapy.
Cataland SR
Biol Blood Marrow Transplant; 2014 Apr; 20(4):438-9. PubMed ID: 24534107
[No Abstract] [Full Text] [Related]
10. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
[TBL] [Abstract][Full Text] [Related]
11. The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy.
Gabr JB; Bilal H; Mirchia K; Perl A
J Investig Med High Impact Case Rep; 2020; 8():2324709620947266. PubMed ID: 32757799
[TBL] [Abstract][Full Text] [Related]
12. Eculizumab deposits in vessel walls in thrombotic microangiopathy.
Cassol CA; Brodsky SV; Satoskar AA; Blissett AR; Cataland S; Nadasdy T
Kidney Int; 2019 Sep; 96(3):761-768. PubMed ID: 31345584
[TBL] [Abstract][Full Text] [Related]
13. Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.
Grall M; Daviet F; Chiche NJ; Provot F; Presne C; Coindre JP; Pouteil-Noble C; Karras A; Guerrot D; François A; Benhamou Y; Veyradier A; Frémeaux-Bacchi V; Coppo P; Grangé S
BMC Nephrol; 2021 Jul; 22(1):267. PubMed ID: 34284729
[TBL] [Abstract][Full Text] [Related]
14. Primary antiphospholipid syndrome presented as thrombotic microangiopathy in renal transplantation.
Bada-Bosch T; Redondo B; Sevillano AM; Alonso M; Trujillo H; Auñón P; Polanco N; Rodríguez L; Gonzalez E; Andrés A
Nefrologia (Engl Ed); 2020; 40(1):108-110. PubMed ID: 31431303
[No Abstract] [Full Text] [Related]
15. Successful long-term treatment of TMA with eculizumab in a transplanted patient with atypical hemolytic uremic syndrome due to MCP mutation.
Reuter S; Heitplatz B; Pavenstädt H; Suwelack B
Transplantation; 2013 Nov; 96(10):e74-6. PubMed ID: 24247905
[No Abstract] [Full Text] [Related]
16. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
[TBL] [Abstract][Full Text] [Related]
17. The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report.
Bjørkto MH; Barratt-Due A; Nordøy I; Dörje C; Galteland E; Lind A; Hilli A; Aukrust P; Mjøen G
BMC Infect Dis; 2021 Feb; 21(1):137. PubMed ID: 33526010
[TBL] [Abstract][Full Text] [Related]
18. Eculizumab and thrombotic microangiopathy after hematopoietic stem cell transplantation: A report on its efficacy and safety in two pediatric patients.
Genere L; Bacchetta J; Bertrand Y; Javouhey E; Cheikh N; Sellier-Leclerc AL
Arch Pediatr; 2018 Nov; 25(8):485-488. PubMed ID: 30340942
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.
El-Husseini A; Hannan S; Awad A; Jennings S; Cornea V; Sawaya BP
Am J Kidney Dis; 2015 Jan; 65(1):127-30. PubMed ID: 25446020
[TBL] [Abstract][Full Text] [Related]
20. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
Fani FM; Patera A; Delsante M; Rossi GM; Manenti L; Landini S; Regolisti G; Fiaccadori E
G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
